| 38 Treffer |
| ART-NR | PRODUKT | HERSTELLER | MENGE | PREIS |
| Cay10277-1 |
CAS: 912758-00-0 COX-1 inhibitor, COX-2 inhibitor  ATB-337 is a hybrid molecule of an H2S donor and the NSAID diclofenac. In rats, diclofenac at 10-50 µmol/kg caused significant gastrointestinal damage, whereas no damage was observed with ATB-337 treatment at the same dose. ATB-337 at 50 µmol/kg does no ... mehr MW: 504 D Formula: C32H15NCl2O2S3 Purity: >98% |
Cayman |
1 mg |
32 €
 |
| Cay10277-10 |
CAS: 912758-00-0 COX-1 inhibitor, COX-2 inhibitor ATB-337 is a hybrid molecule of an H2S donor and the NSAID diclofenac. In rats, diclofenac at 10-50 µmol/kg caused significant gastrointestinal damage, whereas no damage was observed with ATB-337 treatment at the same dose. ATB-337 at 50 µmol/kg does no ... mehr MW: 504 D Formula: C32H15NCl2O2S3 Purity: >98% |
Cayman |
10 mg |
260 €
|
| Cay10277-5 |
CAS: 912758-00-0 COX-1 inhibitor, COX-2 inhibitor ATB-337 is a hybrid molecule of an H2S donor and the NSAID diclofenac. In rats, diclofenac at 10-50 µmol/kg caused significant gastrointestinal damage, whereas no damage was observed with ATB-337 treatment at the same dose. ATB-337 at 50 µmol/kg does no ... mehr MW: 504 D Formula: C32H15NCl2O2S3 Purity: >98% |
Cayman |
5 mg |
146 €
|
| Cay10277-50 |
CAS: 912758-00-0 COX-1 inhibitor, COX-2 inhibitor ATB-337 is a hybrid molecule of an H2S donor and the NSAID diclofenac. In rats, diclofenac at 10-50 µmol/kg caused significant gastrointestinal damage, whereas no damage was observed with ATB-337 treatment at the same dose. ATB-337 at 50 µmol/kg does no ... mehr MW: 504 D Formula: C32H15NCl2O2S3 Purity: >98% |
Cayman |
50 mg |
1137 €
|
| Cay460101-1 |
COX inhibitor screening assay COX-2 (ovine) COX inhibitor screening |
Cayman |
1 each |
63 €
|
| Cay70210-10 |
CAS: 340267-36-9 COX-2 inhibitor CAY10404 is one of the most selective inhibitors of COX-2 which has been reported to date, with a selectivity index (SI, SI = IC50 COX-1/IC50 COX-2) of >500,000. MW: 367 D Formula: C17H12F3NO3S Purity: >98% |
Cayman |
10 mg |
167 €
|
| Cay70210-5 |
CAS: 340267-36-9 COX-2 inhibitor CAY10404 is one of the most selective inhibitors of COX-2 which has been reported to date, with a selectivity index (SI, SI = IC50 COX-1/IC50 COX-2) of >500,000. MW: 367 D Formula: C17H12F3NO3S Purity: >98% |
Cayman |
5 mg |
94 €
|
| Cay70210-50 |
CAS: 340267-36-9 COX-2 inhibitor CAY10404 is one of the most selective inhibitors of COX-2 which has been reported to date, with a selectivity index (SI, SI = IC50 COX-1/IC50 COX-2) of >500,000. MW: 367 D Formula: C17H12F3NO3S Purity: >98% |
Cayman |
50 mg |
731 €
|
| Cay70271-10 |
COX-2 inhibitor Indomethacin derivative which shows enhanced selectivity for the COX-2 isoform. IC50 for indomethacin heptyl ester for the inhibition of human recombinant COX-2 is 0.04 µM. MW: 456 D Formula: C26H30ClNO4 Purity: >98% |
Cayman |
10 mg |
176 €
|
| Cay70271-5 |
COX-2 inhibitor Indomethacin derivative which shows enhanced selectivity for the COX-2 isoform. IC50 for indomethacin heptyl ester for the inhibition of human recombinant COX-2 is 0.04 µM. MW: 456 D Formula: C26H30ClNO4 Purity: >98% |
Cayman |
5 mg |
99 €
|
| Cay70271-50 |
COX-2 inhibitor Indomethacin derivative which shows enhanced selectivity for the COX-2 isoform. IC50 for indomethacin heptyl ester for the inhibition of human recombinant COX-2 is 0.04 µM. MW: 456 D Formula: C26H30ClNO4 Purity: >98% |
Cayman |
50 mg |
771 €
|
| Cay70272-10 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. N-2PIA inhibits human recombinant and ovine COX-2 with IC50 values of 0.06 and 0.125 µM, respectively. MW: 461 D Formula: C27H25ClN2O3 Purity: >98% |
Cayman |
10 mg |
121 €
|
| Cay70272-5 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. N-2PIA inhibits human recombinant and ovine COX-2 with IC50 values of 0.06 and 0.125 µM, respectively. MW: 461 D Formula: C27H25ClN2O3 Purity: >98% |
Cayman |
5 mg |
68 €
|
| Cay70272-50 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. N-2PIA inhibits human recombinant and ovine COX-2 with IC50 values of 0.06 and 0.125 µM, respectively. MW: 461 D Formula: C27H25ClN2O3 Purity: >98% |
Cayman |
50 mg |
528 €
|
| Cay70273-10 |
COX-2 inhibitor The IC50 values of indomethacin N-octyl amide for the inhibition of ovine COX-1 and human recombinant COX-2 are 66 µM and 40 nM, respectively, making it 1,650 times more potent as an inhibitor of COX-2 than COX-1. MW: 469 D Formula: C27H33ClN2O3 Purity: >98% |
Cayman |
10 mg |
176 €
|
| Cay70273-5 |
COX-2 inhibitor The IC50 values of indomethacin N-octyl amide for the inhibition of ovine COX-1 and human recombinant COX-2 are 66 µM and 40 nM, respectively, making it 1,650 times more potent as an inhibitor of COX-2 than COX-1. MW: 469 D Formula: C27H33ClN2O3 Purity: >98% |
Cayman |
5 mg |
99 €
|
| Cay70273-50 |
COX-2 inhibitor The IC50 values of indomethacin N-octyl amide for the inhibition of ovine COX-1 and human recombinant COX-2 are 66 µM and 40 nM, respectively, making it 1,650 times more potent as an inhibitor of COX-2 than COX-1. MW: 469 D Formula: C27H33ClN2O3 Purity: >98% |
Cayman |
50 mg |
771 €
|
| Cay70274-10 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. Selectively inhibits human recombinant COX-2 with an IC50 of 0.052 µM. It is about 1,300 times less potent as an inhibitor of ovine recombinant COX-1. MW: 433 D Formula: C24H20ClN3O3 Purity: >98% |
Cayman |
10 mg |
121 €
|
| Cay70274-5 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. Selectively inhibits human recombinant COX-2 with an IC50 of 0.052 µM. It is about 1,300 times less potent as an inhibitor of ovine recombinant COX-1. MW: 433 D Formula: C24H20ClN3O3 Purity: >98% |
Cayman |
5 mg |
68 €
|
| Cay70274-50 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. Selectively inhibits human recombinant COX-2 with an IC50 of 0.052 µM. It is about 1,300 times less potent as an inhibitor of ovine recombinant COX-1. MW: 433 D Formula: C24H20ClN3O3 Purity: >98% |
Cayman |
50 mg |
528 €
|
| Cay70278-10 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. It inhibits human recombinant and ovine COX-2 with IC50 values of 0.12 and 0.625 µM, respectively. It is about 400 times less potent as an inhibitor of human recombinant COX-1. MW: 490 D Formula: C27H24ClN3O4 Purity: >98% |
Cayman |
10 mg |
121 €
|
| Cay70278-5 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. It inhibits human recombinant and ovine COX-2 with IC50 values of 0.12 and 0.625 µM, respectively. It is about 400 times less potent as an inhibitor of human recombinant COX-1. MW: 490 D Formula: C27H24ClN3O4 Purity: >98% |
Cayman |
5 mg |
68 €
|
| Cay70278-50 |
COX-2 inhibitor Potent and selective reversible inhibitor of COX-2. It inhibits human recombinant and ovine COX-2 with IC50 values of 0.12 and 0.625 µM, respectively. It is about 400 times less potent as an inhibitor of human recombinant COX-1. MW: 490 D Formula: C27H24ClN3O4 Purity: >98% |
Cayman |
50 mg |
528 €
|
| Cay70590-10 |
CAS: 123653-11-2 COX-2 inhibitor NS-398 is a selective inhibitor of cyclooxygenase-2 (COX-2). The IC50 values for human recombinant COX-1 and -2 are 75 and 1.77 µM, respectively. The IC50 values for ovine COX-1 and -2 are 220 and 0.15 µM, respectively. MW: 314 D Formula: C13H18N2O5S Purity: >98% |
Cayman |
10 mg |
84 €
|
| Cay70590-25 |
CAS: 123653-11-2 COX-2 inhibitor NS-398 is a selective inhibitor of cyclooxygenase-2 (COX-2). The IC50 values for human recombinant COX-1 and -2 are 75 and 1.77 µM, respectively. The IC50 values for ovine COX-1 and -2 are 220 and 0.15 µM, respectively. MW: 314 D Formula: C13H18N2O5S Purity: >98% |
Cayman |
25 mg |
198 €
|
| Cay70590-5 |
CAS: 123653-11-2 COX-2 inhibitor NS-398 is a selective inhibitor of cyclooxygenase-2 (COX-2). The IC50 values for human recombinant COX-1 and -2 are 75 and 1.77 µM, respectively. The IC50 values for ovine COX-1 and -2 are 220 and 0.15 µM, respectively. MW: 314 D Formula: C13H18N2O5S Purity: >98% |
Cayman |
5 mg |
44 €
|
| Cay70590-50 |
CAS: 123653-11-2 COX-2 inhibitor NS-398 is a selective inhibitor of cyclooxygenase-2 (COX-2). The IC50 values for human recombinant COX-1 and -2 are 75 and 1.77 µM, respectively. The IC50 values for ovine COX-1 and -2 are 220 and 0.15 µM, respectively. MW: 314 D Formula: C13H18N2O5S Purity: >98% |
Cayman |
50 mg |
353 €
|
| Cay70635-10 |
CAS: 443919-96-8 COX-2 inhibitor, 5-LO inhibitor COX-2/5-LO inhibitors such as CAY10416 are apoptosis-inducing agents and are potentially useful in prostate cancer chemotherapy. MW: 536 D Formula: C29H29FN2O5S Purity: >95% |
Cayman |
10 mg |
399 €
|
| Cay70635-5 |
CAS: 443919-96-8 COX-2 inhibitor, 5-LO inhibitor COX-2/5-LO inhibitors such as CAY10416 are apoptosis-inducing agents and are potentially useful in prostate cancer chemotherapy. MW: 536 D Formula: C29H29FN2O5S Purity: >95% |
Cayman |
5 mg |
225 €
|
| Cay70635-50 |
CAS: 443919-96-8 COX-2 inhibitor, 5-LO inhibitor COX-2/5-LO inhibitors such as CAY10416 are apoptosis-inducing agents and are potentially useful in prostate cancer chemotherapy. MW: 536 D Formula: C29H29FN2O5S Purity: >95% |
Cayman |
50 mg |
1746 €
|
| Cay70640-25000 |
CAS: 51803-78-2 COX-2 inhibitor Nimesulide is a selective inhibitor of COX-2. The IC50 values are 70 and 1.27 µM for human recombinant COX-1 and -2 (at 20 µM arachidonic acid), respectively. MW: 308 D Formula: C13H12N2O5S Purity: >99% |
Cayman |
25 g |
278 €
|
| Cay70640-5000 |
CAS: 51803-78-2 COX-2 inhibitor Nimesulide is a selective inhibitor of COX-2. The IC50 values are 70 and 1.27 µM for human recombinant COX-1 and -2 (at 20 µM arachidonic acid), respectively. MW: 308 D Formula: C13H12N2O5S Purity: >99% |
Cayman |
5 g |
74 €
|
| Cay70645-10 |
CAS: 88149-94-4 COX-2 inhibitor DuP-697 is a member of the diaryl heterocycle group of selective COX-2 inhibitors which includes MK-966 (rofecoxib), SC-58125, and celecoxib. DuP-697 is a potent and time-dependent inhibitor of COX-2. MW: 411 D Formula: C17H12BrFO2S2 Purity: >96% |
Cayman |
10 mg |
225 €
|
| Cay70645-25 |
CAS: 88149-94-4 COX-2 inhibitor DuP-697 is a member of the diaryl heterocycle group of selective COX-2 inhibitors which includes MK-966 (rofecoxib), SC-58125, and celecoxib. DuP-697 is a potent and time-dependent inhibitor of COX-2. MW: 411 D Formula: C17H12BrFO2S2 Purity: >96% |
Cayman |
25 mg |
532 €
|
| Cay70645-5 |
CAS: 88149-94-4 COX-2 inhibitor DuP-697 is a member of the diaryl heterocycle group of selective COX-2 inhibitors which includes MK-966 (rofecoxib), SC-58125, and celecoxib. DuP-697 is a potent and time-dependent inhibitor of COX-2. MW: 411 D Formula: C17H12BrFO2S2 Purity: >96% |
Cayman |
5 mg |
118 €
|
| Cay70645-50 |
CAS: 88149-94-4 COX-2 inhibitor DuP-697 is a member of the diaryl heterocycle group of selective COX-2 inhibitors which includes MK-966 (rofecoxib), SC-58125, and celecoxib. DuP-697 is a potent and time-dependent inhibitor of COX-2. MW: 411 D Formula: C17H12BrFO2S2 Purity: >96% |
Cayman |
50 mg |
947 €
|
| Cay70650-100000 |
CAS: 4394-00-7 COX-2 inhibitor Niflumic acid is a selective inhibitor of COX-2. The IC50 values are 16 and 0.1 µM for human recombinant COX-1 and -2, respectively. The Ki values are 2 and 0.02 µM for ovine COX-1 and -2, respectively. MW: 282 D Formula: C13H9F3N2O2 Purity: >99% |
Cayman |
100 g |
260 €
|
| Cay70650-50000 |
CAS: 4394-00-7 COX-2 inhibitor Niflumic acid is a selective inhibitor of COX-2. The IC50 values are 16 and 0.1 µM for human recombinant COX-1 and -2, respectively. The Ki values are 2 and 0.02 µM for ovine COX-1 and -2, respectively. MW: 282 D Formula: C13H9F3N2O2 Purity: >99% |
Cayman |
50 g |
148 €
|
Warenkorb
